Skip to main content

Table 1 Cox univariate and multivariate analysis of biochemical recurrence free survival and progression free survival according to RBM3 expression

From: High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

   Progression free survival
RBM3 intensity*fraction dichotomized HR (95% CI) p-value
  n (events)   
Univariate    
Low (0-2) 64 (18) 1.00  
High (3-8) 24 (1) 0.09 (0.01-0.71) 0.021
Multivariate    
Low (0-2) 64 (16) 1.00  
High (3-8) 24 (1) 0.06 (0.01-0.50) 0.009
   BCR free survival
RBM3 intensity*fraction continuous HR (95% CI) p-value
  n (events)   
Univariate 88 (14) 0.56 (0.34-0.93) 0.024
Multivariate 88 (12) 0.41 (0.19-0.89) 0.024
  1. Multivariate analysis including adjustments for preoperative PSA level, Gleason score, presence or absence of extracapsular extension, seminal vesicle invasion and positive surgical margins.